This review reports the results of application of short peptides in glioma therapy clinical trials, their rises and falls.
Browsing: Disease Area > Brain and neurologic
Researchers have uncovered a novel method of overriding the growth promoting effects of PTEN deletion and the answer is to inhibit another tumor suppressor gene.
Primary research to evaluate whether Recursive Partitioning Analysis or Graded Prognostic Assessment is more useful to clinicians.
The European Commission has approved dinutuximab beta for the treatment of high-risk neuroblastoma patients over the age of 12 months, making it the only approved immunotherapy for these patients in Europe.
A comprehensive review article of the avaliable therapeutic strategies developed against malignant gliomas based on ‘actively targeted’ nanoparticles, it discusses challenges, mechanisms, clinical studies and treatment options
This editorial provides and insight into proton beam therapy as a promising treatment for pediatric cancers, it covers the cost effectiveness, clinical concerns and future prospective of the therapy.
Discover more about the molecular profiles of brain metastases from colorectal cancer and corresponding primary tumors with a focus on KRAS, NRAS, BRAF and PIK3CA in this research article from Future Oncology.
Survival gains reported in a phase I trial of a cytomegalovirus pp65-targeted vaccine for glioblastoma.
A team of investigators on the Head Start III trial have highlighted that patients with reduced radiotherapy experience a worse prognosis following deviations from the treatment protocol.